Who Paid My Doc
Taunna Jones
Podiatrist, Foot Surgery Oxon Hill, MD Doctor of Podiatric Medicine
NPI 1346564747 CMS profile 1291151
6710 Oxon Hill Rd Ste 210, Oxon Hill, MD 20745
General payments
$27
Research payments
$0
Ownership & investment interest
$0
Through program year 2020, Taunna Jones of Oxon Hill, MD is reported in the CMS Open Payments database as having received $27 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 5th percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2020 | General | $27 | 1 |
Beside peers
- Taunna Jones
- Podiatrist, Foot Surgery median
- Middle half of Podiatrist, Foot Surgery
- National median
In program year 2025, general payments to Taunna Jones were reported at $0. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.
Show as a table
| Year | Taunna Jones | Podiatrist, Foot Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $167 | $67–$484 | $163 |
| 2020 | $27 | $114 | $40–$323 | $114 |
| 2021 | $0 | $171 | $57–$502 | $132 |
| 2022 | $0 | $196 | $66–$556 | $149 |
| 2023 | $0 | $187 | $78–$466 | $160 |
| 2024 | $0 | $190 | $78–$557 | $164 |
| 2025 | $0 | $180 | $70–$569 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
588
Drug cost
$13,480
Branded share of claims
4.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ammonium Lactate | Generic | 207 | $4,924 | |
| Ciclopirox | Generic | 119 | $4,573 | |
| Ketoconazole | Generic | 206 | $3,532 | |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | Brand | 24 | $332 | |
| Mupirocin | Generic | 15 | $110 | |
| Meloxicam | Generic | 17 | $9 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot Surgery in Maryland
Jacob Wynes
Podiatrist, Foot Surgery · Baltimore, MD
Herman Zarate
Podiatrist, Foot Surgery · Takoma Park, MD
Vesta McDowell
Podiatrist, Foot Surgery · Bowie, MD
Kiana Trent
Podiatrist, Foot Surgery · Baltimore, MD
Ronald Sherman
Podiatrist, Foot Surgery · Baltimore, MD
Aaron Lewis
Podiatrist, Foot Surgery · Landover, MD
Related records
Podiatrist, Foot Surgery in Maryland
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Maryland
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.